Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 2Lymphoid 1

Conditions

Radiotherapy-induced Oral Mucositis 1Radiation-induced Oral Mucositis 1Lymphoma, Mantle-Cell 1

Interventions

Magnetic Resonance Spectroscopy 262Specimen Handling 253pembrolizumab 230Cyclophosphamide 216Radiotherapy 204Nivolumab 168Cisplatin 161Carboplatin 145Biopsy 144Radiosurgery 128fludarabine 123Blood Specimen Collection 116Gemcitabine 111Paclitaxel 107Surveys and Questionnaires 106Standard of Care 102venetoclax 94Dexamethasone 93Bevacizumab 92Radiation 87Rituximab 81Capecitabine 80Cytarabine 79Oxaliplatin 77Drug Therapy 75Doxorubicin 75Ipilimumab 73durvalumab 70fludarabine phosphate 69atezolizumab 68

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Mouthwashes × 90 days × Clear all
NCT03623373 2026-04-21

Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma

Washington University School of Medicine

Phase 2 Completed
13 enrolled 13 charts
Lymphoid

Lymphoma, Mantle-Cell

NCT07282483 2026-03-25

Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients

West China Hospital

Phase 2 Recruiting
118 enrolled
Other

Radiation-induced Oral Mucositis

NCT07339774 2026-03-25

Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.

West China Hospital

Phase 2 Recruiting
128 enrolled
Other

Radiotherapy-induced Oral Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡